G2-M-IS: Glaukos iStent Inject Trabecular Micro-Bypass Stent System

Sign in to add this product to your favorites!
| Price: | $320.00 $160.00 per box of 1 |
|---|---|
| Quantity: | |
| In Stock: | 6 box of 1 |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 12 hours 58 minutes and choose overnight shipping at checkout. |
Related Items
IS3 $399.00 per box of 1 Glaukos iStent Infinite Trabecular Micro-Bypass Stent System Expired Units in stock: 1 box of 1 | Order Qty |
G2-W $299.00 $149.50 per box of 1 Glaukos iStent Inject W Trabecular Micro-Bypass System Expired Units in stock: 38 box of 1 | Order Qty |
GTS100L $299.00 $149.50 per box of 1 Glaukos iStent Trabecular Micro-Bypass Stent System, Left Expired Units in stock: 18 box of 1 | Order Qty |
GTS100R $299.00 $149.50 per box of 1 Glaukos iStent Trabecular Micro-Bypass Stent System, Right Expired Units in stock: 11 box of 1 | Order Qty |
10-0066 $499.00 $299.40 per box of 1 New World Medical, Streamline Surgical System Ophthalmic Instrument Expired Units in stock: 14 box of 1 | Order Qty |
S1.1391 $46.50 per box of 1 FCI Self-Retaining Bicanaliculus Intubation Set, 30mm Expired Units in stock: 1 box of 1 | Order Qty |
5513-001 $399.00 per box of 1 AbbVie Allergan XEN 45 Gel Stent Ophthalmic Implant, Glaucoma Treatment System Expired Units in stock: 5 box of 1 | Order Qty |
S1.1361 $10.00 per box of 1 FCI Nunchaku Self-Retaining Bicanaliculus Intubation Stent, 90mm for Children Expired Units in stock: 2 box of 1 | Order Qty |
S1.1535 $15.00 per box of 1 FCI LacriJet Preloaded, Self-Retaining Monocanalicular Nasolacrimal Intubation 35mm Expired Units in stock: 1 box of 1 | Order Qty |
F00022 $299.00 $224.25 per box of 1 Alcon Ivantis Hydrus Microstent Expired Units in stock: 36 box of 1 | Order Qty |
S1.1545 $15.00 EACH FCI LacriJet Preloaded, Self-Retaining Monocanalicular Nasolacrimal Intubation 45mm Expired Units in stock: 1 | Order Qty |
S1.1450 $15.00 per box of 3 FCI Ritleng Lacrimal Bicanaliculus Intubation Set, Silicone, 300mm, 0.64mm Expired Units in stock: 1 box of 3 | Order Qty |
S1.1490 $5.00 EACH FCI Ritleng Lacrimal Bicanaliculus Intubation Set, Silicone + PVP, 300mm, 0.64mm Expired Units in stock: 12 | Order Qty |
EAG-1085 $19.00 EACH Katena EagleVision Monostent Monocanalicular Stent Expired Units in stock: 4 | Order Qty |
CP250 $149.00 $119.20 per box of 1 New World Medical Ahmed ClearPath Glaucoma Drainage Device Expired Units in stock: 6 box of 1 | Order Qty |
CP350 $199.00 $149.25 per box of 1 New World Medical Ahmed ClearPath Glaucoma Drainage Device Expired Units in stock: 21 box of 1 | Order Qty |
Model FP8 $209.00 per box of 1 New World Medical Ahmed Glaucoma Valve, Flexible Plate Expired Units in stock: 1 box of 1 | Order Qty |
8590350 $6.00 EACH BVI Beaver Visitec Guibor Canaliculus Intubation Set (CIS) 0.64mm x 17.7cm Probe, 0.64mm x 29cm Biocompatible Silicone Tubing Expired Units in stock: 2 | Order Qty |
8590350 $30.00 per box of 5 BVI Beaver Visitec Guibor Canaliculus Intubation Set (CIS) 0.64mm x 17.7cm Probe, 0.64mm x 29cm Biocompatible Silicone Tubing Expired Units in stock: 2 box of 5 | Order Qty |
AccessGUDID Info
- FDA Product Code: OGO
- FDA Product Code Name: Intraocular Pressure Lowering Implant
- GMDN Term Code: 62945
- GMDN Term Name: Glaucoma micro-stent
- GMDN Term Description: A non-bioabsorbable device designed to be implanted in Schlemm’s canal (within the eye) for the restoration of aqueous humour outflow and subsequent reduction of intraocular pressure as part of treatment for open angle glaucoma. It is a metallic device which may be intended to dilate, support, and/or create a channel into Schlemm’s canal; disposable devices associated with implantation (e.g., delivery system) may be included.
Manufacturer
Glaukos is a medical technology company specializing in innovative treatments for glaucoma, corneal disorders, and retinal diseases. The company is best known for pioneering minimally invasive glaucoma surgery (MIGS) with the iStent family of devices, which are implanted during cataract surgery to reduce intraocular pressure in patients with open-angle glaucoma. Glaukos has expanded its portfolio to include the iStent inject W and iStent infinite, as well as the iDose TR, a sustained-release intraocular drug delivery implant. The company is also advancing therapies in corneal cross-linking and retinal disease through its pipeline of biologics and sustained drug delivery platforms. Glaukos is focused on transforming the standard of care in chronic eye disease with safe, effective, and minimally invasive solutions.
IN-DATE